Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors. (Q36219738)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083346%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083346%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083346%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

William P Malachowski

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083346%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

George C Prendergast

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083346%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083346%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Targets

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083346%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083346%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083346%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

831-849

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083346%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

cites work

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Tuning tumor-specific T-cell activation: a matter of costimulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Enzymic formation of D-kynurenine from D-tryptophan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Gene structure of human indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Analysis of transcription factors regulating induction of indoleamine 2,3-dioxygenase by IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma-inducible expression of human indoleamine 2,3-dioxygenase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Tolerance, DCs and tryptophan: much ado about IDO

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Regulation of indoleamine 2,3-dioxygenase activity in the small intestine and the epididymis of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Tryptophan and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Prevention of allogeneic fetal rejection by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Inhibition of T cell proliferation by macrophage tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Characterisation of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

CTLA-4-Ig regulates tryptophan catabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

21 January 2018

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Modulation of tryptophan catabolism by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

IDO and tolerance to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Tumor Expression of 4-1BB Ligand Sustains Tumor Lytic T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

The comparative pathology of human and mouse mammary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Immunomodulating anticancer alkylating drugs: targets and mechanisms of activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

New degradative routes of 5-hydroxytryptophan and serotonin by intestinal tryptophan 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Heme-Containing Oxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Inhibition of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by beta-carboline and indole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

β-Carboline-3-carboxylic acid ethyl ester antagonizes diazepam activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Biomimetic approach to potential benzodiazepine receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Simultaneous determination of tryptophan and kynurenine in serum by HPLC with UV and fluorescence detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Neopterin as a marker for activated cell-mediated immunity: application in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831

Spinning molecular immunology into successful immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.4.831